Navigation Links
Regeneron Announces September 2009 Investment Conference Presentations
Date:9/10/2009

TARRYTOWN, N.Y., Sept. 10 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations that are scheduled for delivery later this month at the following investment conferences:

  • The Morgan Stanley Global Healthcare Unplugged Conference at 8:00 a.m. Eastern Time on Tuesday, September 15
  • The NewsMakers in the Biotech Industry Conference at 9:00 a.m. Eastern Time on Wednesday, September 16
  • The ThinkEquity Annual Growth Conference at 2:00 p.m. Eastern Time on Thursday, September 17
  • The UBS Global Life Sciences Conference at 9:00 a.m. Eastern Time on Monday, September 21

The presentation at the Morgan Stanley Global Healthcare Unplugged Conference will be a conversation with Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, and a Morgan Stanley analyst. The presentations at the other conferences will provide an overview of the Company, including its three Phase 3 clinical programs.

The sessions may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page under the Presentations heading. Archived versions of the presentations will be available for thirty days after the live webcasts. Additional information about Regeneron and recent news releases are available on the Regeneron web site.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST(R) (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.

    Contact Information:
    Peter Dworkin                   Laura Lindsay
    Investor Relations              Media Relations
    914.345.7640                    914.345.7800
    peter.dworkin@regeneron.com     laura.lindsay@regeneron.com


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amedica Announces New Global Headquarters
2. Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces
3. TEDIndia Announces List of Inspiring Speakers from Across the Globe
4. Inverness Medical Innovations Announces September Investor Conference Schedule
5. JHD Group Announces TURNKEY EHR(TM) Service
6. SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund
7. VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform
8. Patriot Scientific Corporation Announces Alcon Inc.s Purchase of a Moore Microprocessor Patent(TM) Portfolio License
9. QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
10. NBTY To Web Cast Presentation at CL King Best Ideas Conference; Announces Preliminary Unaudited Net Sales Results For August 2009
11. Sambazon Announces Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... its executive staff with the addition of industry sales leader, Thomas (Tom) Slott, ... develop the national distribution and sales network, direct the efforts of the surgical ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: